Menu
Back to Journals » Clinical Ophthalmology » Volume 13
Clinical Trial Report
A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,162 | Dovepress* | 7,572+ | 1,965 | 9,537 | |
| PubMed Central* | 1,590 | 260 | 1,850 | ||
| Totals | 9,162 | 2,225 | 11,387 | ||
| *Since 12 February 2019 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed Central and Google Scholar